Launch Decision Domain
Market Access & Regulatory
Guidance on how market, product category, evidence and regulatory boundaries shape the correct CDMO development route before commitments are made.
3
guides
Launch Strategy
Launching Clinician-Branded Dietary Supplements and Medical Nutrition Products Across Priority Markets
The primary challenge is correctly classifying clinician-branded products across diverse markets, differentiating between conventional supplements and medical nutrition, which dictates claims and launch pathways.
Market Access & Regulatory
Navigating Health Supplement vs. Medical Food Classification for Launch in Dubai
The primary risk for market entry in Dubai is misclassifying a product as a health supplement when it should be a food for special medical purposes (FSMP), leading to regulatory delays, rejection, and re-design. This critical decision impacts product architecture, intended-use claims, channel strategy, and required evidence package.
Market Access & Regulatory
Global Medical Food and FSMP Market Entry: Navigating Regulatory Pathways and Commercial Strategy
Defining and classifying a nutritional product accurately as a medical food or FSMP from the initial development phase presents a significant challenge, requiring precise alignment with specific disease-linked nutritional needs and avoiding common pitfalls of mislabeling or unsubstantiated claims.
No guides match the selected topic on this page. Try another tag or clear the filter.
A Complex Decision Deserves a Defined Scope
Need a Product Decision Built Around Your Specific Programme?
These guides help you frame the right questions. Product-specific formulation, market, evidence and technical decisions belong in a defined Paid Discovery or bespoke FSMP scope.